I 
114TH CONGRESS 
2D SESSION 
H. R. 5073 
To establish EUREKA Prize Competitions to accelerate discovery and devel-
opment of disease-modifying, preventive, or curative treatments for Alz-
heimer’s disease and related dementia, to encourage efforts to enhance 
detection and diagnosis of such diseases, or to enhance the quality 
and efficiency of care of individuals with such diseases. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 27, 2016 
Mr. COHEN (for himself, Mr. DUNCAN of Tennessee, and Ms. KUSTER) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce 
A BILL 
To establish EUREKA Prize Competitions to accelerate dis-
covery and development of disease-modifying, preventive, 
or curative treatments for Alzheimer’s disease and re-
lated dementia, to encourage efforts to enhance detection 
and diagnosis of such diseases, or to enhance the quality 
and efficiency of care of individuals with such diseases. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Ensuring Useful Re-
search Expenditures is Key for Alzheimer’s Act’’ or the 
‘‘EUREKA Act’’. 
SEC. 2. AUTHORIZATION OF NATIONAL ALZHEIMER’S AND 
DEMENTIA 
RESEARCH 
BREAKTHROUGH 
PRIZE COMPETITIONS. 
Part B of title IV of the Public Health Service Act 
(42 U.S.C. 284 et seq.) is amended by adding at the end 
the following: 
‘‘SEC. 409K. NATIONAL ALZHEIMER’S AND DEMENTIA RE-
SEARCH BREAKTHROUGH PRIZE COMPETI-
TIONS. 
‘‘(a) IN GENERAL.—The Director of NIH, in con-
sultation with the Director of the National Science Foun-
dation, the Director of the Defense Advanced Research 
Projects Agency, the Commissioner of Food and Drugs, 
the Director of the Intelligence Advanced Research 
Projects Activity, and the heads of any other appropriate 
Federal agencies that have experience in prize competi-
tions, shall establish prize competitions. The competitions 
shall be designed to achieve high-priority breakthroughs 
to achieve the national goals of preventing and treating 
Alzheimer’s disease by 2025, enhancing quality and effi-
ciency of care for individuals with Alzheimer’s disease, and 
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS
expanding supports for individuals with Alzheimer’s dis-
ease and the family caregivers of such individuals. 
‘‘(b) EUREKA PRIZE COMPETITIONS.— 
‘‘(1) IN GENERAL.—The Director of NIH, in 
consultation with the Director of the National 
Science Foundation, the Director of the Defense Ad-
vanced Research Projects Agency, the Commissioner 
of Food and Drugs, the Director of the Intelligence 
Advanced Research Projects Activity, and the heads 
of any other appropriate Federal agencies that have 
experience in prize competitions, and when appro-
priate, in coordination with private organizations, 
shall establish EUREKA prize competitions to accel-
erate breakthroughs in the area of Alzheimer’s dis-
ease and dementia that lead to the attainment of 
critical milestones set forth in the competitions. The 
competitions may be in any of the following areas: 
‘‘(A) Identification and validation of non- 
invasive biomarkers to inform therapeutic tar-
geting. 
‘‘(B) 
Identification 
of 
scalable, 
non- 
invasive means of early detection and diagnosis 
of Alzheimer’s disease. 
‘‘(C) Repurposing of a drug approved by 
the Food and Drug Administration as a dis-
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS